Advertisement
Advertisement

IBIO

IBIO logo

iBio, Inc. Common Stock

1.55
USD
Sponsored
-0.10
-6.06%
Jun 16, 15:52 UTC -4
Closed
exchange

After-Market

1.59

+0.04
+2.58%

IBIO Earnings Reports

Positive Surprise Ratio

IBIO beat 7 of 19 last estimates.

37%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

iBio, Inc. Common Stock earnings per share and revenue

On May 12, 2026, IBIO reported earnings of -0.07 USD per share (EPS) for Q3 26, missing the estimate of -0.06 USD, resulting in a -9.55% surprise. Revenue reached --, compared to an expected 20.40 thousand, with a -100.00% difference. The market reacted with a -3.73% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q3 2026, iBio, Inc. Common Stock reported EPS of -$0.07, missing estimates by -9.55%, and revenue of $0.00, -100% below expectations.
The stock price moved down -3.73%, changed from $1.61 before the earnings release to $1.55 the day after.
The next earning report is scheduled for --.
Based on -- analysts, iBio, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement